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Higher fiber intake is associated 
with lower blood pressure levels 
in patients with type 1 diabetes
Mileni Vanti Beretta1,2, Fernanda R. Bernaud1, Ciglea Nascimento1,  
Thais Steemburgo2, Ticiana C. Rodrigues1,3
ABSTRACT
Objective: The present investigation sought to evaluate the potential association between dietary fiber 
intake and blood pressure (BP) in adult patients with type 1 diabetes (T1D). Subjects and methods: 
A cross-sectional study was carried out in 111 outpatients with T1D from Porto Alegre, Brazil. Patients 
were predominantly male (56%) and white (88%), with a mean age of 40 ± 10 years, diabetes duration 
of 18 ± 9 years, BMI 24.8 ± 3.85 kg/m2, and HbA1c 9.0 ± 2.0%. After clinical and laboratory evaluation, 
dietary intake was evaluated by 3-day weighed-diet records, whose reliability was confirmed by 24-h 
urinary nitrogen output. Patients were stratified into two groups according to adequacy of fiber intake 
in relation to American Diabetes Association (ADA) recommendations: below recommended daily 
intake (< 14g fiber/1000 kcal) or at/above recommended intake (≥ 14g/1000 kcal). Results: Patients 
in the higher fiber intake group exhibited significantly lower systolic (SBP) (115.9 ± 12.2 vs 125.1 ± 
25.0 mmHg, p = 0.016) and diastolic blood pressure (DBP) (72.9 ± 9.2 vs 78.5 ± 9.3 mmHg, p = 0.009), 
higher energy intake (2164.0 ± 626.0 vs 1632.8 ± 502.0 kcal, p < 0.001), and lower BMI (24.4 ± 3.5 vs 
26.2 ± 4.8, p = 0.044). Linear regression modelling, adjusted for age, energy intake, sodium intake, and 
BMI, indicated that higher fiber intake was associated with lower SBP and DBP levels. No significant 
between-group differences were observed with regard to duration of diabetes, glycemic control, 
insulin dosage, or presence of hypertension, nephropathy, or retinopathy. Conclusion: We conclude 
that fiber consumption meeting or exceeding current ADA recommendations is associated with lower 
SBP and DBP in patients with T1D. Arch Endocrinol Metab. 2018;62(1):40-7
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T he American Diabetes Association has specific dietary recommendations for individuals with type 
1 diabetes (T1D) (1), which include: preferring whole 
grains and fiber; preferring fructose naturally current 
in fruits; restricted intake of saturated fats, trans fats, 
and cholesterol; and keeping daily sodium intake under 
2,300 mg. In addition, regarding fiber in particular, the 
recommended intake is 14 g total fiber per 1000 kcal 
of energy intake, or approximately 25 g/day for adult 
women and 38 g/day for adult men. However, most 
studies evaluating fiber intake in persons with diabetes 
have been limited by short observation periods and 
small sample sizes, and by assessing combinations of 
fiber-rich diets and foods with low glycaemic index, 
which may have hindered analysis of the isolated effect 
of fiber as a determinant of improved glycaemic control 
in patients with diabetes (2,3).
Some observational studies have demonstrated 
an inverse relationship between total fiber intake and 
blood pressure (BP) levels (4,5). Intake of fiber from 
natural dietary sources, such as whole grains, fruits, 
and pulses, appears to have a beneficial effect on BP 
and on serum cholesterol levels in individuals with 
type 2 diabetes (T2D) (6,7). Furthermore, in patients 
with T1D and T2D, a high-fiber diet (40 g/day) was 
associated with significant reductions in fasting and 
post-prandial blood sugar levels (8). In T1D, dietary 
fiber plays important roles in lipid profile, glyceamic 
control, several parameters related to obesity, risk of 
cardiovascular disease (CVD), endothelial dysfunction, 
and markers of inflammation (9-12).
Current recommendations for the dietary treatment 
of hypertension in patients with diabetes, although 
evidence-based, are largely drawn from studies not 
conducted in diabetic populations. In fact, the effects 
of dietary fiber on BP in patients with T1D has been 
the subject of little research. One recent study of 



















Association of high fiber intake with blood pressure in diabetes type 1
Arch Endocrinol Metab. 2018;62/1 
fiber, especially soluble fiber, against CVD and all-cause 
mortality (9).
The role of fiber in the presence of hypertension in 
patients with T1D has yet to be established definitively. 
Within this context, the aim of the present study was 
to evaluate a potential association between dietary 
fiber intake (in accordance with American Diabetes 




This cross-sectional study was carried out on a cohort 
of patients with T1D recruited consecutively from the 
outpatient endocrinology clinic of Hospital de Clínicas de 
Porto Alegre, a large teaching hospital in Porto Alegre, 
Brazil. T1D was defined as diabetes with onset before 
40 years of age, ketonuria or ketonaemia at the time of 
diagnosis, and dependence on insulin therapy to sustain 
life. Patients were selected on the basis of the following 
criteria: dietary counselling by a dietitian during the 6 
months preceding study enrolment; age > 18 years; and 
duration of diabetes > 5 years. Patients with renal failure, 
symptomatic heart failure (NYHA class III or IV), 
acute cardiovascular events in the 6 months preceding 
study enrolment (stroke, myocardial infarction, or acute 
pulmonary oedema), or inability to complete weighed 
dietary records were excluded from the cohort. All 
ongoing medications were maintained, except for statins.
The recruitment process took place from January 
2011 to December 2012, and all participants provided 
written informed consent for inclusion in the study. 
The study protocol was approved by the Hospital de 
Clínicas de Porto Alegre Research Ethics Committee 
(number 08-470).
Clinical evaluation
All patients were evaluated by an endocrinologist and 
interviewed on past medical history, demographic data, 
medication use, and current lifestyle. Patients were 
classified by ethnicity as white or non-white. Smoking 
status was classified dichotomously (as smoker or non-
smoker), as was current alcohol intake (present or 
absent). The frequency of physical exercise was graded 
into four levels using a standardised questionnaire, 
based on activities carried out during a typical day (13); 
level 1 corresponded to a sedentary lifestyle.
Sitting BP was measured in triplicate, in the 
left arm, after a 10-minute rest, using a digital 
sphygmomanometer (Omron® HEM-705 CP). 
Hypertension was defined as BP readings ≥ 140/90 
mmHg on two separate occasions, or current 
antihypertensive therapy (14). All patients underwent 
a full physical examination.
The presence of diabetic nephropathy (DN) was 
classified according to the results of a random spot 
urine sample or 24-hour timed urinary collection (at 
least two samples obtained 6 months apart). Patients 
were considered normoalbuminuric when the urinary 
albumin excretion (UAE) rate was < 17 mg/L or < 
20 μg/min; microalbuminuric when the UAE was 17-
174 mg/L or 20-199 mg/min; and macroalbuminuric 
when the UAE was > 176 mg/L or > 199 mg/min on 
at least two occasions during a 2-month period (15).
Diabetic retinopathy (DR) was assessed by an 
ophthalmologist. DR was detected by dilated-pupil 
direct and indirect ophthalmoscopy, and graded by 
severity using the Global Diabetic Retinopathy Project 
Group scale (16) as ‘absence of DR’, ‘mild non-
proliferative DR’ (NPDR), ‘moderate NPDR’, ‘severe 
DR’, or ‘proliferative DR’ (PDR). For purposes of 
analysis, patients were divided into two groups (absence 
or presence of DR, regardless of severity).
Nutritional evaluation
Nutritional evaluation was carried out as described 
previously (11). Briefly, dietary habits were assessed 
by means of 3-day weighed food records (two non-
consecutive weekdays and one weekend day), as 
previously standardised (17,18).
The adequacy of dietary records was evaluated 
by comparing reported protein intake to protein 
intake estimated from 24-hour urinary urea nitrogen, 
collected on the third day of dietary records (17). The 
ratio of reported protein intake to estimated protein 
intake was considered acceptable when in the range of 
0.79 to 1.26 (18).
The nutrient contents of dietary records were 
analised in NutriBase 2007 Clinical Nutrition Manager 
(Cybersoft, Phoenix, AZ, USA), version 7.14 (19). 
Nutrient intake was expressed as the percentage of total 
daily energy intake (%) and in grams amounts (g/day 
or mg/day). Nutrition facts for frequently consumed 
foods were updated and/or supplemented as necessary 
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The total, soluble, and insoluble fiber content was 
estimated according to data provided in the CRC 
Handbook of Dietary Fiber in Human Nutrition 
(20). Dietary sources of fiber were based on the foods 
described by patients in their 3-day weighed food 
records. The main sources of dietary fiber consumed 
by the cohort were pulses (beans, lentils, peas), whole-
grain foods (granola, wholemeal bread, wholegrain 
biscuits/crackers, flaxseed, sesame seeds, sunflower 
seeds, quinoa, amaranth), rice, barley, potatoes, sweet 
potatoes, cassava (manioc), eddoes, taro, wheat, and 
fruits such as apple, banana, clementine, grape, mango, 
orange, papaya, peach, and pineapple. Vegetables were 
grouped in two categories on the basis of carbohydrate 
content (% of grams weight), with group A vegetables 
containing up to 5% and group B vegetables containing 
up to 10% carbohydrate (21).
Laboratory evaluation
HbA1c was measured by high-performance liquid 
chromatography (Merck-Hitachi 9100; Merck®, 
Darmstadt, Germany) (reference range 4.7-6.0%). 
Fasting plasma glucose was measured by the 
glucose-peroxidase enzymatic colorimetric method 
(Biodiagnostica®). Total serum cholesterol and 
triglycerides were measured by enzymatic colorimetric 
methods (ADVIA 1800® Autoanalyzer, Germany), 
and HDL cholesterol by the homogeneous direct 
method (ADVIA 1800® Autoanalyzer, Germany). 
High-sensitivity C-reactive protein (hs-CRP) was 
quantitated by the turbidimetric method (ADVIA 
1800® Autoanalyzer, Germany), and fibrinogen was 
determined by the Clauss clotting method, which 
measures the rate of fibrinogen conversion to fibrin in a 
diluted sample under the influence of excess thrombin. 
Urinary urea was measured by an enzymatic ultraviolet 
assay (ADVIA 1800® Autoanalyzer, Germany).
Statistical analyses
Data are presented as mean ± standard deviation 
(SD), n (%), or median (interquartile range). Baseline 
characteristics were compared by fiber intake status 
by means of Student’s t-test and Mann–Whitney 
U test. Patients were stratified into two groups on 
the basis of fiber intake in relation to American 
Diabetes Association recommendations: intake below 
recommendations (< 14 g/1000 kcal/day) or intake 
meeting/exceeding recommendations (≥ 14 g/1000 
kcal/day). To determine the association between 
blood pressure and higher fiber intake (≥ 14 g/1000 
kcal/day), a linear regression model was constructed 
with systolic (SBP) and diastolic (DBP) blood pressure 
values as the dependent variables. The multivariate 
model was adjusted for age, total calorie intake, BMI 
and sodium intake. All analyses were carried out in 
SPSS 18.0 (Chicago, IL, USA).
RESULTS
Of the 111 patients evaluated, 56% were male and 88% 
were white. The mean age was 40.0 ± 10.0 years, and 
mean duration of diabetes was 18.0 ± 9.0 years. Mean 
BMI was 24.8 ± 3.85 kg/m2 and mean HbA1c was 9.0 
± 2.0%. Table 1 describes the clinical and laboratory 
characteristics of the sample stratified by fiber intake. 
There were no significant differences between the lower 
and higher fiber intake groups in terms of age, gender, 
ethnicity, duration of diabetes, physical activity level, or 
alcohol consumption. Patients in the high fiber intake 
group had a lower mean BMI than did those in the low 
fiber intake group (24.4 ± 3.5 vs 26.2 ± 4.8 kg/m2, 
p = 0.044). There were no between-group differences 
in waist circumference or presence of hypertension. 
Regarding BP, patients in the higher fiber intake group 
(≥ 14 g/1000 kcal/day) had lower SBP (115.9 ± 12.2 
vs 125.1 ± 25.0 mmHg, p = 0.016) and DBP (73.0 
± 9.2 vs 78.5 ± 9.3 mmHg, p = 0.009) than patients 
who consumed less fiber per day than recommended 
(< 14 g/1000 kcal/day). In addition, patients in the 
higher fiber intake group used lower doses of insulin. 
A similar, significant difference was found regarding 
antihypertensive therapy: fewer patients were on 
angiotensin-converting enzyme (ACE) inhibitors in 
the higher fiber intake group than in the lower fiber 
intake group (11.5% vs 20.8%, p < 0.001). There were 
no between-group differences in glycaemic control 
(HbA1c or serum glucose levels), presence of DN or 
DR, or lipid profile (total cholesterol, HDL cholesterol, 
LDL cholesterol, and triglycerides).
Daily macronutrient intake values, according to 
adequacy of fiber intake, are described in Table 2. 
Patients in the adequate fiber intake group had higher 
intakes of total energy, carbohydrates, protein, and 
fat than did patients who consumed less than the 
recommended adequate intake of fiber. Significant 
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of fat fractions (saturated, monounsaturated, and 
polyunsaturated). Furthermore, patients in the higher 
fiber intake group had a significantly higher daily intake 
of sodium (2360.64 ± 919,81 vs 1676.59 ± 688.01 
mg/day; p = 0.004). There were no between-group 
differences in intake of trans fats or cholesterol.
Table 3 describes the daily fiber intake, stratified by 
type and source, in our sample. As expected, patients 
in the high fiber intake group (≥ 14g/1000 kcal) 
consumed more total, soluble, and insoluble fiber than 
did their counterparts in the below-adequate fiber 
intake group. Analysis of the main sources of dietary 
Table 1. Clinical and laboratory profile of patients with type 1 DM, stratified by adequacy of fiber intake (American Diabetes Association) (1)
Below recommended fiber intake  
(< 14 g/1000 kcal/day)
At or above recommended fiber 
intake (≥ 14 g/1000 kcal/day) P
N 24 87 -
Age (years) 37 ± 13 40 ± 11 0.161†
Sex (male) 29.2% 56.3% 0.180‡
Ethnicity (white) 91.7% 83.9% 0.451‡
Duration of diabetes (years) 19.4 ± 11.0 17.6 ± 8.6 0.394†
Physical activity: level 1* (%) 54.2 46.0 0.811‡
Alcohol intake (%) 54.5 56.2 0.893‡
BMI (kg/m²) 26.2 ± 4.8 24.4 ± 3.5 0.044†
Weight (kg) 70.40 ± 12.92 69.02 ± 10.73 0.632†
Height (cm) 162.95 ± 9.15 169.21 ± 9.21 0.004†
Waist circumference (cm) 83.0 ± 8.5 83.3 ± 9.8 0.856†
Males 78.40 ± 6.22 86.51 ± 9.14 0.059†
Females 83.30 ± 8.08 79.54 ± 9.44 0.210†
Hypertension (%) 40.9 38.2 0.815‡
SBP (mmHg) 125.1 ± 25.0 115.9 ± 12.2 0.016†
DBP (mmHg) 78.5 ± 9.3 72.9 ± 9.2 0.009†
Under treatment for hypertension 58.3% 32.2% 0.161
ACE inhibitor 20.8% 11.5% < 0.001
ACE inhibitor + diuretic 12.5% 12.6% 0.813
Diuretic 4.2% 1.1% 0.250
Calcium channel blocker 4.2% 0.0% < 0.001
ACE inhibitor + beta blocker + diuretic 8.3% 2.3% 0.043
Insulin dosage
IU/kg body weight 53.88 ± 21.91 47.80 ± 19.34 0.240†
Diabetic nephropathy (%) 0.80 ± 0.26 0.67 ± 0.25 0.061†
Diabetic retinopathy (%) 20.8 12.6 0.312‡
HbA1c (%) 10.7 9.7 0.472‡
Plasma glucose (mg/dL) 90.7 ± 2.5 90.0 ± 1.8 0.079†
Cholesterol, total (mg/dL) 241.33 ± 160.0 193.0 ± 107.0 0.084†
Cholesterol, HDL (mg/dL) 194.2 ± 30 187.3 ± 37 0.408†
Cholesterol, LDL (mg/dL) 60.0 ± 17.0 59.5 ± 16.3 0.884†
Triglycerides (mg/dL) 116.6 ± 31.0 111.5 ± 35.0 0.511†
hs-CRP (mg/L) 98.5 (49-207) 88.1 (34.0-223.0) 0.315†
Fibrinogen (mg/dL) 2.5 (0.1-7.3) 2.1 (0.1-8.4) 0.566†
Urinary sodium excretion (mg/24h) 408.1 (225-672) 364.3 (208-667.0) 0.088†
Data expressed as mean ± SD, median (IQR), or n (%). † Student’s t test. ‡ chi-square test. * Level 1: sedentary.
ACE: angiotensin-converting enzyme; BMI: body mass index; DBP: diastolic blood pressure; HbA1c: glycated haemoglobin; HDL: high-density lipoprotein; hs-CRP: high-sensitivity C-reactive protein; 
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fiber revealed a significant between-group difference in 
the intake of fiber from pulses. Patients in the high fiber 
intake group consumed a greater amount of total fiber 
from pulses than did patients in the below-adequate 
fiber intake group (7.8 vs 1.6 g/day; p < 0.001). There 
were no significant between-group differences in terms 
of total fiber intake from vegetables (groups A+B), 
tubers, and whole grains. 
Furthermore, we observed inverse correlations 
between total fiber, soluble fiber, and insoluble fiber 
intake with BP levels (r = -0.219, p = 0.021; r = -0.221, 
p = 0.02; and r = -0.215, p = 0.02 respectively).
Linear regression models (Table 4 and Table 5) 
were constructed to evaluate potential associations 
between BP levels and higher fiber intake (≥ 14g/1000 
kcal). The models were adjusted for age, total energy 
intake, BMI and sodium intake. Analysis revealed that 
lower SBP and DBP levels were associated with higher 
fiber intake (beta -11.11, p = 0.01 and -6.21, p = 0.005 
respectively), independent of the adjustments.
DISCUSSION
The present study demonstrated an association 
between increased dietary fiber intake and lower BP 
levels in patients with T1D. Patients whose daily fiber 
intake met or exceeded American Diabetes Association 
recommendations (≥ 14g/1000 kcal) exhibited lower 
SBP and DBP levels. These associations remained 
significant after adjustment for potential confounding 
factors (age, total energy intake, sodium intake, and 
BMI). Furthermore, we observed an association 
between fiber type and BP. Increased intake of soluble 
and insoluble fiber was negatively associated with BP 
levels. In this patient group, the mean total fiber intake 
was 19.8 ± 7.2 g/day (5.8 ± 2.4 g from soluble and 
Table 2. Daily nutrient intake of patients with type 1 DM, stratified by adequacy of fiber intake (American Diabetes Association) (1)
Below recommended fiber intake 
(< 14 g/1000 kcal/day)
At or above recommended fiber 
intake (≥ 14 g/1000 kcal/day) P
n 24 87 -
Total energy intake (kcal/day) 1632.8 ± 502.0 2164.0 ± 626 0.001†
Total energy intake (KJ) 6821.76 9045.52 0.001†
Total energy intake (kcal/body weight/day) 24.09 ± 7.3 31.24 ± 8.0 0.001†
Carbohydrate
g/day 201.7 ± 71.0 269.6 ± 86.5 0.001†
% of total energy intake 49.5 ± 7.6 50.2 ± 8.6 0.899†
Protein
g/day 74.9 ± 27.1 98.1 ± 33.0 0.002†
% of total energy intake 18.4 ± 3.5 18.3 ± 3.6 0.742†
Fat, total
g/day 57.6 ± 22.8 77.5 ± 34.5 0.009†
% of total energy intake 31.6 ± 8.3 31.7 ± 9.4 0.952†
Fat, saturated
g/day 17.8 ± 9.0 24.2 ± 10.5 0.007†
% of total energy intake 9.5 ± 2.3 10.0 ± 3.1 0.648†
Fat, monounsaturated 21.0 ± 8.6 27.0 ± 12.6 0.031†
g/day 21.0 ± 9.8 27.6 ± 12.2 0.021†
% of total energy intake 9.5 ± 3.1 11.1 ± 3.5 0.627†
Fat, polyunsaturated
g/day 12.0 (1.98-23.65) 19.0 (2.7-66.1) 0.026§
% of total energy intake 7.0 (1.73-12.78) 7.7 (1.8-27.3) 0.519§
Fat, trans (g/day) 0.2 (0.0-2.58) 0.3 (0.0-4.0) 0.770§
Cholesterol, dietary (mg/day) 224.7 ± 171.9 231.3 ± 109.0 0.818†
Sodium (mg/day) 1676.59 ± 688.01 2360.64 ± 919.81 0.004†
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14.0 ± 5.3 g from insoluble fiber). The main sources of 
dietary fiber associated with significant differences were 
pulses (beans, lentils, peas) and fruit (banana, apple, 
papaya, pineapple, clementine, orange, grape, mango, 
and peach).
The type of dietary fiber appears to play an important 
role in the risk of cardiovascular disease (CVD) in 
patients with T1D. Schoenaker and cols. (9) evaluated 
2,108 patients with T1D aged 15 to 60 years and found 
that those who consumed at least 5 g of soluble fiber per 
day experienced a 16% reduction in CVD risk. In the 
present study, we evaluated parameters associated with 
CVD, such as lipid profile, and found no significant 
association between increased fiber intake (≥ 14g/1000 
kcal/day) and serum levels of total cholesterol, HDL 
cholesterol, or LDL cholesterol. 
In this sample of patients with T1D, the higher 
fiber intake group (≥ 14 g/1000 kcal/day) was also 
found to have higher energy and macronutrient 
(carbohydrate, protein, and fat) intake than patients in 
the lower fiber consumption group (< 14 g/1000 kcal/
day). Interestingly, despite this increased energy and 
macronutrient intake, patients in the higher fiber intake 
group also had lower BMI, superior metabolic control 
of diabetes, and inferior use of medications to treat 
diabetes (insulin) and hypertension (ACE inhibitors). 
Patients in the higher fiber intake group also consumed 
more sodium than their counterparts in the lower 
fiber intake group, although without exceeding the 
recommended daily intake of sodium for diabetics (22). 
Sacks and cols. (23) evaluated the effect of the 
Dietary Approaches to Stop Hypertension (DASH) 
diet in hypertensive and normotensive (but non-
diabetic) individuals. Those who followed the DASH 
diet showed significant reductions in BP as compared 
with those who did not follow the diet. De Paula and 
cols. (24) analyzed the impact of fiber intake on the 
BP of 225 patients with T2D. Patients were stratified 
by BP tertiles, and patients in the subgroup with the 
highest BP levels (i.e., the top tertile) were found to 
consume less fruits and vegetables and fewer portions 
of dairy than recommended in the DASH diet. 
A prospective study evaluated the association 
between quantity and variety of fruits and vegetables 
in the diet and incidence of diabetes (25), and found 
that increased intake of these foods was associated 
Table 3. Daily fiber intake, types of fiber and their main dietary sources in 





(< 14 g/1000 
kcal/day)
At or above 
recommended 
fiber intake  
(≥ 14 g/1000 
kcal/day)
P
n 24 87 -
Fiber (g/day)
Total 10.4 ± 2.0 22.9 ± 7.4 < 0.001†
Soluble 3.2 ± 1.6 6.5 ± 2.2 < 0.001†
Insoluble 7.6 ± 2.0 15.8 ± 4.5 < 0.001†
Dietary sources (g/day)
Fiber from fruita 1.2 (0.0 – 3.5) 2.7 (0.0-10.2) 0.010§
Fiber from 
vegetables (A+B)b
1.2 (0.0 – 3.5) 2.8 (0.0-47.2) 0.208§
Fiber from tubersc 0.5 (0.0 – 2.2) 0.5 (0.0-3.5) 0.791§
Fiber from whole 
grainsd
1.5 (0.0 – 6.5) 2.3 (0.0-12.4) 0.292§
Fiber from pulsese 1.6 (0.0 – 5.8) 7.8 (0.0-26.0) < 0.001§
Data expressed as mean ± SD or median (IQR).† t test. § Mann–Whitney U.
a Fruit: apple, banana, clementine, grape, mango, orange, papaya, peach, pineapple.
b A vegetables: cabbage, chard, cress, cucumber, kale, lettuce, mustard greens, radish, rocket, 
spinach, turnip.
b B vegetables: aubergine (cooked), beets (cooked), broccoli, carrot (cooked), cauliflower 
(cooked), chayote (cooked), courgette (cooked), hearts of palm, onion, peppers, runner beans, 
squash/marrow (cooked).
c Tubers: potatoes, sweet potatoes, cassava (manioc), eddoes, taro. 
d Whole grains: granola, wholemeal bread, wholegrain biscuits/crackers, wholemeal flour, oats, 
flaxseed, quinoa, amaranth, sunflower seeds.
e Pulses: beans, lentils, peas. 
Table 4. Linear regression analysis: systolic blood pressure and adequate 
fiber intake (≥ 14g fiber/1000 kcal). Model adjusted for age, total energy 
intake, BMI, and sodium intake 
Variables β P
≥ 14g fiber/1000 kcal -11.11 0.010
Age (years) 0.03 0.810
Total energy intake 
(kcal/day)
- 0.004 0.200
BMI (kg/m²) 0.032 0.930
Sodium intake (mg/day) 0.03 0.031
BMI: body mass index.
Table 5. Linear regression analysis: diastolic blood pressure and adequate 
fiber intake (≥ 14g fiber/1000 kcal). Model adjusted for age, total energy 
intake, BMI, and sodium intake
Variables β P
-6.21 0.005
≥ 14g fiber/1000 kcal -0.18 0.040
Age (years) 0.005 0.009
Total energy intake 
(kcal/day)
0.14 0.550
BMI (kg/m²) -0.001 0.310
Sodium intake (mg/day) -6.21 0.005
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with a lower risk of developing any diabetes (21%). 
Furthermore, increased consumption of fruits alone, 
vegetables alone, and both fruits and vegetables was 
associated with significant reductions in the risk of T2D 
(30%, 22%, and 39%, respectively). In the present study, 
we observed that fiber from beans/pulses and from 
fruit was a particularly important dietary component that 
may be associated with BP levels in patients with T1D.
The mechanisms by which dietary fibers lead to 
lower BP levels have not yet been elucidated (26). 
However, is well established in the literature that 
both soluble and insoluble fibers exert a protective 
and preventive effect in some pathologies such as 
metabolic syndrome, CVD and hyperlipidemia (27), 
in addition, it has an important role as evidenced in 
satiety and weight loss (28). Dietary fiber intake 
appears to improve serum lipids levels (29) and this 
reduction can be associated with improved endothelial 
vasodilation and consequently with reduced BP levels 
(27,29). Based on these findings and our observation 
that the group of patients with higher fiber intake also 
consumed more energy, including all macronutrients as 
well as sodium, we suggest that fiber intake may have 
a favorable effect on vasodilatation and on oxidative 
stress. Additional studies are needed to elucidate the 
mechanisms involved in the proposed beneficial effects 
of fiber intake on BP levels.
A potential limitation of the present study is that 
BP was only measured during the first study visit and 
when patients returned to submit their food records. 
In an ideal setting, 24-hour ambulatory BP monitoring 
would have been performed. Nevertheless, given the 
lack of studies demonstrating specific effects of fiber 
intake on BP level in patients with T1D, our study is 
highly relevant to clinical practice.
In conclusion, increased total fiber intake is 
associated with lower SBP and DBP in patients with 
T1D. Future studies, including randomized clinical 
trials should confirm the beneficial effects of dietary 
fiber (of different types and sources) on BP levels in 
patients with T1D.
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